Ob/Gyn Medical News about vulvar dermatoses

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Topical calcineurin inhibitors for the treatment of vulvar dermatoses
European Journal of Obstetrics & Gynecology and Reproductive Biology , 08/25/09

Goldstein AT et al. – The available data suggest that both topical calcineurin inhibitors may be effective and well tolerated in these vulvar dermatoses, although topical pimecrolimus may exhibit a better long–term tolerability profile. Being devoid of steroid–related side effects, they may represent a useful second–line therapeutic option for patients who are intolerant of, or resistant to topical corticosteroids.

<< Previous
Pre-Pregnancy Overweight Status between Successive Pregnancies...

Next >>
Correlates of Cervicovaginal Human Papillomavirus Detection in...